Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1076-38-6

Post Buying Request

1076-38-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1076-38-6 Usage

Chemical Properties

Yellow powder or chunks or Slightly yellow needle-like crystals. freely soluble in ethanol, ether and hot water. brown in color with ferric chloride.

Uses

Different sources of media describe the Uses of 1076-38-6 differently. You can refer to the following data:
1. 4-Hydroxycoumarin is a plant derived antioxidant, protecting against lipid peroxidation, as well as a potential inhibitor of HIV-1 Integrase. 4-Hydroxycoumarins are a very important class of biologically active drugs which are widely used as anticoagulants-Warfarin and Acenocoumarol.
2. 4-Hydroxycoumarin may be regarded as a phenylenetetronic acid , and like tetronic acid forms condensation products with aldehydes. Synthesis of biscoumarin derivatives by the reaction of aldehydes and 4-hydroxycoumarin using ruthenium(III) chloride hydrate as a versatile homogeneous catalyst.
3. 4-Hydroxycoumarin is involved in annulation reactions, due to the relatively high acidity of the C-H bond at the 3-position: a three-component reaction with isocyanides and dialkyl acetylene dicarboxylates affords annulated 4H-pyrans.

Definition

ChEBI: 4-hydroxycoumarin is a hydroxycoumarin that is coumarin in which the hydrogen at position 4 is replaced by a hydroxy group. It is a conjugate acid of a 4-hydroxycoumarin(1-).

Synthesis Reference(s)

The Journal of Organic Chemistry, 25, p. 677, 1960 DOI: 10.1021/jo01074a630

Flammability and Explosibility

Notclassified

Purification Methods

Crystallise 4-hydroxycoumarin from water and dry it in a vacuum desiccator over pKEst Sicapent. [Beilstein 18/1 V 378.]

Check Digit Verification of cas no

The CAS Registry Mumber 1076-38-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,7 and 6 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1076-38:
(6*1)+(5*0)+(4*7)+(3*6)+(2*3)+(1*8)=66
66 % 10 = 6
So 1076-38-6 is a valid CAS Registry Number.
InChI:InChI:1S/C9H6O3/c10-7-5-9(11)12-8-4-2-1-3-6(7)8/h1-5,10H

1076-38-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (H0235)  4-Hydroxycoumarin  >98.0%(GC)(T)

  • 1076-38-6

  • 25g

  • 260.00CNY

  • Detail
  • TCI America

  • (H0235)  4-Hydroxycoumarin  >98.0%(GC)(T)

  • 1076-38-6

  • 250g

  • 1,230.00CNY

  • Detail
  • Alfa Aesar

  • (A14394)  4-Hydroxycoumarin, 98+%   

  • 1076-38-6

  • 100g

  • 354.0CNY

  • Detail
  • Alfa Aesar

  • (A14394)  4-Hydroxycoumarin, 98+%   

  • 1076-38-6

  • 500g

  • 1431.0CNY

  • Detail
  • Alfa Aesar

  • (A14394)  4-Hydroxycoumarin, 98+%   

  • 1076-38-6

  • 2500g

  • 5721.0CNY

  • Detail
  • Vetec

  • (V900550)  4-Hydroxycoumarin  Vetec reagent grade, 98%

  • 1076-38-6

  • V900550-25G

  • 127.53CNY

  • Detail
  • Vetec

  • (V900550)  4-Hydroxycoumarin  Vetec reagent grade, 98%

  • 1076-38-6

  • V900550-100G

  • 327.60CNY

  • Detail
  • Aldrich

  • (H23805)  4-Hydroxycoumarin  98%

  • 1076-38-6

  • H23805-100G

  • 533.52CNY

  • Detail
  • Aldrich

  • (H23805)  4-Hydroxycoumarin  98%

  • 1076-38-6

  • H23805-500G

  • 2,049.84CNY

  • Detail

1076-38-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-hydroxycoumarin

1.2 Other means of identification

Product number -
Other names 4-hydroxy-2H-benzopyran-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1076-38-6 SDS

1076-38-6Synthetic route

carbon monoxide
201230-82-2

carbon monoxide

o-hydroxyacetophenone
118-93-4

o-hydroxyacetophenone

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With selenium; 1,5-Diazabicyclo[5.4.0]undec-5-ene In tetrahydrofuran at 90℃;100%
With selenium; 1,8-diazabicyclo[5.4.0]undec-7-ene In tetrahydrofuran at 100℃; under 22800 Torr; for 30h;100%
With selenium; 1,8-diazabicyclo[5.4.0]undec-7-ene In tetrahydrofuran at 100℃; under 22800 Torr; for 30h; Mechanism; carbonylation of alkyl aryl ketones with CO using stoichiometric amount of Se, variation of temperature and solvent;100%
With triethylamine In tetrahydrofuran at 80℃; under 7355.08 Torr; for 4h;95%
With nitrobenzene; 1,8-diazabicyclo[5.4.0]undec-7-ene; selenium In tetrahydrofuran at 90℃; under 22800 Torr; for 30h; Mechanism; catalytic carbonylation of alkyl aryl ketones with CO by Se in the presence of oxidizing agent;68%
4-allyloxy-2H-chromen-2-one
31005-07-9

4-allyloxy-2H-chromen-2-one

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With sodium hydrogen telluride; acetic acid In ethanol for 2h; Heating;99%
With ammonium formate; palladium on activated charcoal In methanol for 1.5h; Heating;95%
With iodine In dimethyl sulfoxide at 120℃; for 0.5h;78%
ethyl 4-hydroxy-2-oxo-2H-chromene-3-carboxylate
1821-20-1

ethyl 4-hydroxy-2-oxo-2H-chromene-3-carboxylate

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With potassium hydroxide In methanol; water96%
o-hydroxyacetophenone
118-93-4

o-hydroxyacetophenone

Diethyl carbonate
105-58-8

Diethyl carbonate

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With sodium hydride In toluene at 0℃; for 4.5h; Reflux;95%
With sodium hydride In toluene at 100℃; for 3h;85%
Stage #1: o-hydroxyacetophenone With sodium hydride In toluene; mineral oil
Stage #2: Diethyl carbonate In toluene; mineral oil Reflux;
Stage #3: With hydrogenchloride In water
85%
2-oxo-2H-chromen-4-yl propionate
120450-94-4

2-oxo-2H-chromen-4-yl propionate

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With sodium hydrogen telluride In ethanol for 0.5h; Quantum yield; Heating; buffer: deoxygen. acetic acid;95%
4-(piperidin-1-yl)-2H-chromen-2-one
14290-47-2

4-(piperidin-1-yl)-2H-chromen-2-one

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With hydrogenchloride for 0.5h; Product distribution; Heating;94%
3-carbethoxy-4-hydroxycoumarin
66530-08-3

3-carbethoxy-4-hydroxycoumarin

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With sulfuric acid In ethanol; water at 100 - 105℃; for 1h; Hydrolysis; decarboxylation;90.5%
3-acetyl-chroman-2,4-dione
326925-91-1

3-acetyl-chroman-2,4-dione

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With sulfuric acid In ethanol; water for 1h; Deacetylation; Heating;90.2%
N,N-diethyl-3-(2-hydroxyphenyl)-3-oxopropanamide
211449-34-2

N,N-diethyl-3-(2-hydroxyphenyl)-3-oxopropanamide

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With trifluoroacetic acid In toluene for 1h; Heating;89%
C12H14BF2NO5S

C12H14BF2NO5S

A

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

B

3-(2-Hydroxy-phenyl)-N,N-dimethyl-3-oxo-propionamide
144224-85-1

3-(2-Hydroxy-phenyl)-N,N-dimethyl-3-oxo-propionamide

Conditions
ConditionsYield
With sodium hydroxide In acetonitrile at 50℃; for 0.5h;A 7%
B 87%
With sodium hydrogencarbonate In acetonitrile at 50℃; for 1h;A 25%
B 66%
o-hydroxyacetophenone
118-93-4

o-hydroxyacetophenone

carbonic acid dimethyl ester
616-38-6

carbonic acid dimethyl ester

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With sodium hydride In toluene at 100℃; for 3h;84%
malonic acid monophenyl ester
35756-54-8

malonic acid monophenyl ester

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With Eaton’s reagent at 70℃; for 1h;80%
With Eaton’s reagent In water for 2h; Reflux;63%
With eaton’s reagent at 70℃; for 4h; Neat (no solvent);
With Eaton’s reagent at 60 - 70℃;
C11H12BF2NO3

C11H12BF2NO3

A

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

B

3-(2-Hydroxy-phenyl)-N,N-dimethyl-3-oxo-propionamide
144224-85-1

3-(2-Hydroxy-phenyl)-N,N-dimethyl-3-oxo-propionamide

Conditions
ConditionsYield
With sodium hydroxide In acetonitrile at 50℃; for 1h;A 14%
B 77%
With water In acetonitrile at 50℃; for 1h;A 69%
B 29%
C24H18O7
476000-77-8

C24H18O7

A

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

B

dimethyl 2-(4-methylphenyl)furan-3,4-dicarboxylate
82577-50-2

dimethyl 2-(4-methylphenyl)furan-3,4-dicarboxylate

Conditions
ConditionsYield
With hydrogenchloride In methanol Heating;A 77%
B 68%
n-butyl magnesium bromide
693-03-8

n-butyl magnesium bromide

C11H11NO5S

C11H11NO5S

A

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

B

4-butyl-2H-1-benzopyran-2-one
133380-32-2

4-butyl-2H-1-benzopyran-2-one

Conditions
ConditionsYield
With 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone; iron(III)-acetylacetonate In tetrahydrofuran at 0℃; for 0.166667h; Reagent/catalyst; Inert atmosphere;A 21%
B 70%
phosgene
75-44-5

phosgene

o-hydroxyacetophenone
118-93-4

o-hydroxyacetophenone

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With sodium hydride In toluene at 100℃; for 3h;69%
2-trichloromethyl-4-chromone
36853-28-8

2-trichloromethyl-4-chromone

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With potassium hydroxide In methanol for 0.5h; Hydrolysis; Heating;65%
2-acetylphenyl 2-chlorobenzoate
84634-61-7

2-acetylphenyl 2-chlorobenzoate

methyl chloroformate
79-22-1

methyl chloroformate

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
Stage #1: 2-acetylphenyl 2-chlorobenzoate With sodium hydride In N,N-dimethyl-formamide at 100℃; for 6h; Inert atmosphere;
Stage #2: methyl chloroformate In N,N-dimethyl-formamide
59%
3-(phenyl-λ3-iodanylidene)chromane-2,4-dione
86795-49-5

3-(phenyl-λ3-iodanylidene)chromane-2,4-dione

A

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

B

3,4-Dihydroxy-2-oxo-2H<1>benzopyran
77889-64-6

3,4-Dihydroxy-2-oxo-2H<1>benzopyran

C

3-Acetoxy-4-hydroxy-2-oxo-2H<1>benzopyran

3-Acetoxy-4-hydroxy-2-oxo-2H<1>benzopyran

Conditions
ConditionsYield
With acetic acid for 0.0833333h; Heating;A n/a
B 13%
C 51%
3-(phenyl-λ3-iodanylidene)chromane-2,4-dione
86795-49-5

3-(phenyl-λ3-iodanylidene)chromane-2,4-dione

acetic acid
64-19-7

acetic acid

A

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

B

3,4-Dihydroxy-2-oxo-2H<1>benzopyran
77889-64-6

3,4-Dihydroxy-2-oxo-2H<1>benzopyran

C

3-Acetoxy-4-hydroxy-2-oxo-2H<1>benzopyran

3-Acetoxy-4-hydroxy-2-oxo-2H<1>benzopyran

Conditions
ConditionsYield
for 0.0833333h; Heating;A n/a
B 13%
C 51%
malonic acid
141-82-2

malonic acid

phenol
108-95-2

phenol

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With zinc(II) chloride; trichlorophosphate at 60 - 65℃; for 48h;50%
With zinc(II) chloride; trichlorophosphate at 60 - 70℃;48%
With zinc(II) chloride; trichlorophosphate at 60 - 65℃;41%
2-amino-3-formylchromone
61424-76-8

2-amino-3-formylchromone

A

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

B

2-(4-oxo-4H-[1]benzopyran-3-yl) [1] benzopyrano[3,2-e]pyrimidin-5(5H)-one
73262-21-2

2-(4-oxo-4H-[1]benzopyran-3-yl) [1] benzopyrano[3,2-e]pyrimidin-5(5H)-one

C

Bis-<1>benzopyrano<2,3-b:3',2'-e>pyridin-5(5H),7(7H)-dion
90701-02-3

Bis-<1>benzopyrano<2,3-b:3',2'-e>pyridin-5(5H),7(7H)-dion

Conditions
ConditionsYield
hydrogenchloride In isopropyl alcohol for 30h;A 26%
B 1%
C 38%
4-chloro-3-nitro-chromen-2-one
38464-20-9

4-chloro-3-nitro-chromen-2-one

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With pyridine; sodium dithionite In water27%
3-(phenyl-λ3-iodanylidene)chromane-2,4-dione
86795-49-5

3-(phenyl-λ3-iodanylidene)chromane-2,4-dione

A

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

B

C27H14O9

C27H14O9

Conditions
ConditionsYield
With trifluoroacetic acid Heating;A n/a
B 25%
4-(o-hydroxybenzoyl)-pyrazolone-5
91595-89-0

4-(o-hydroxybenzoyl)-pyrazolone-5

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With hydrogenchloride at 100℃; for 10h;15.6%
C18H12FN3O4S

C18H12FN3O4S

A

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

B

N-(4-fluorophenyl)-1,3,4-thiadiazole-2-carboxamide

N-(4-fluorophenyl)-1,3,4-thiadiazole-2-carboxamide

Conditions
ConditionsYield
In dimethyl sulfoxide at 20℃;A n/a
B 13%
C19H12F3N3O4S

C19H12F3N3O4S

A

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

B

N-[2-(trifluoromethyl)phenyl]-1,3,4-thiadiazole-2-carboxamide
1456793-06-8

N-[2-(trifluoromethyl)phenyl]-1,3,4-thiadiazole-2-carboxamide

Conditions
ConditionsYield
In dimethyl sulfoxide at 20℃;A n/a
B 9%
methyl acetylsalicylate
580-02-9

methyl acetylsalicylate

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Conditions
ConditionsYield
With sodium at 165 - 175℃;
sodium ethanolate
141-52-6

sodium ethanolate

o-hydroxyacetophenone
118-93-4

o-hydroxyacetophenone

Diethyl carbonate
105-58-8

Diethyl carbonate

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

sodium ethanolate
141-52-6

sodium ethanolate

o-hydroxyacetophenone
118-93-4

o-hydroxyacetophenone

Diethyl carbonate
105-58-8

Diethyl carbonate

benzene
71-43-2

benzene

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

4-methoxy-benzaldehyde
123-11-5

4-methoxy-benzaldehyde

3,3-(4'-methoxybenzylidene)bis(4-hydroxycoumarin)
10172-75-5

3,3-(4'-methoxybenzylidene)bis(4-hydroxycoumarin)

Conditions
ConditionsYield
With 4-sulfophthalic acid In water at 80℃; for 0.416667h; Catalytic behavior; Green chemistry;100%
With 1,8-diazabicyclo[5.4.0]undec-7-ene at 20℃; for 16h;99%
With phosphotungstic acid In water at 80℃; for 0.383333h; domino Knoevenagel type condensation/Michael reaction;99%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

3,3'-(4-chlorophenylmethylene)-bis-4-hydroxycoumarin
4322-59-2

3,3'-(4-chlorophenylmethylene)-bis-4-hydroxycoumarin

Conditions
ConditionsYield
With glycerol-based carbon sulfonic acid In ethanol; water at 80℃; for 0.333333h; Solvent; Temperature; Concentration;100%
With silica-supported Preyssler acid nanoparticles In ethanol at 25℃; for 0.333333h;99%
With cholin hydroxide In water at 50℃; for 2h;99%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

benzaldehyde
100-52-7

benzaldehyde

3,3'-phenylmethylene-bis-4-hydroxycoumarin
1821-19-8

3,3'-phenylmethylene-bis-4-hydroxycoumarin

Conditions
ConditionsYield
With cholin hydroxide In water at 50℃; for 1h; Catalytic behavior; Temperature; Reagent/catalyst;100%
With 4-sulfophthalic acid In water at 80℃; for 0.5h; Catalytic behavior; Green chemistry;99%
With C19H40KNO8S(2+)*2C2F3O2(1-) In ethanol; water for 0.5h; Reagent/catalyst; Reflux;98%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

phenol
108-95-2

phenol

2-oxo-2H-chromen-4-yl propionate
120450-94-4

2-oxo-2H-chromen-4-yl propionate

Conditions
ConditionsYield
With pyridine In benzene100%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

3-methoxy-benzaldehyde
591-31-1

3-methoxy-benzaldehyde

3,3'-((3-methoxyphenyl)methylene)bis(4-hydroxy-2H-chromen-2-one)
10172-74-4

3,3'-((3-methoxyphenyl)methylene)bis(4-hydroxy-2H-chromen-2-one)

Conditions
ConditionsYield
With 4-sulfophthalic acid In water at 80℃; for 0.333333h; Catalytic behavior; Green chemistry;100%
With piperidine In ethanol at 20℃; for 4h;98%
With 4-aminobenzene sulfonic acid In water at 80℃; for 0.366667h; Green chemistry;96%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

4-bromo-benzaldehyde
1122-91-4

4-bromo-benzaldehyde

acetonitrile
75-05-8

acetonitrile

N-[(4-bromophenyl)(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]acetamide
1092452-47-5

N-[(4-bromophenyl)(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]acetamide

Conditions
ConditionsYield
With chlorosulfonic acid at 20℃; for 1h;100%
Stage #1: 4-hydroxy[1]benzopyran-2-one; 4-bromo-benzaldehyde; acetonitrile With phosphorus pentaoxide; Hexamethyldisiloxane at 20℃; for 3h;
Stage #2: With water cooling; Further stages.;
90%
pyrrolidine
123-75-1

pyrrolidine

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

benzaldehyde
100-52-7

benzaldehyde

4-hydroxy-3-(phenyl(pyrrolidin-1-yl)methyl)-2H-chromen-2-one
1330776-87-8

4-hydroxy-3-(phenyl(pyrrolidin-1-yl)methyl)-2H-chromen-2-one

Conditions
ConditionsYield
In dichloromethane at 20℃; for 2h; Mannich Aminomethylation;100%
With zinc(II) oxide In water at 25℃; for 0.416667h;93%
With Triton X-100 In water at 20℃; for 6h; Mannich type reaction;90%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

C8H7NO5
5000-63-5

C8H7NO5

malononitrile
109-77-3

malononitrile

2-amino-3-cyano-4-(3'-nitrobenzoyl)-4H,5H-pyrano[3,2-c]chromene-5-one
1613226-36-0

2-amino-3-cyano-4-(3'-nitrobenzoyl)-4H,5H-pyrano[3,2-c]chromene-5-one

Conditions
ConditionsYield
With zinc(II) oxide In ethanol; water at 20℃; for 1.83333h; Reflux; Green chemistry;100%
With ammonium dihydrogen phosphate In ethanol; water at 20℃; for 1.5h; Reflux;85%
With ammonium ferrous sulphate hexahydrate In ethanol; water at 20℃; for 2.33333h; Reflux; Green chemistry; chemoselective reaction;85%
With titanium(IV) oxide In ethanol; water at 20℃; for 2h; Reflux; Green chemistry;80%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

p-Chlorothiophenol
106-54-7

p-Chlorothiophenol

3-(4-chlorophenylsulfanyl)-4-hydroxy-2H-chromen-2-one

3-(4-chlorophenylsulfanyl)-4-hydroxy-2H-chromen-2-one

Conditions
ConditionsYield
With iodine; dimethyl sulfoxide In neat (no solvent) at 80℃; for 5h;100%
With sodium tetrafluoroborate; potassium iodide In acetonitrile at 60℃; for 6h; Temperature; Electrolysis;94%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

thiophenol
108-98-5

thiophenol

4-hydroxy-3-(phenylsulfanyl)-2H-chromen-2-one
18714-37-9

4-hydroxy-3-(phenylsulfanyl)-2H-chromen-2-one

Conditions
ConditionsYield
With iodine; dimethyl sulfoxide In neat (no solvent) at 80℃; for 5h;100%
With iodine In dimethyl sulfoxide at 80℃; for 3h;92%
With tetrabutylammomium bromide; iodine; oxygen; bovine serum albumin In water at 50℃; for 8h; Green chemistry;
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

1-Phenylbut-1-en-3-one
122-57-6

1-Phenylbut-1-en-3-one

warfarin
81-81-2

warfarin

Conditions
ConditionsYield
With C23H24N2O6S*Li(1+) In tetrahydrofuran; dimethyl sulfoxide at 0℃; for 48h; Reagent/catalyst; Michael Addition;99%
With lipase In water at 50℃; for 168h; Temperature; Michael Addition; Enzymatic reaction;99.1%
With N-ethyl-N,N-diisopropylamine In water for 20h; Michael Addition; Reflux;93%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

salicylaldehyde
90-02-8

salicylaldehyde

3,3'‑(2‑hydroxyphenylmethylene)bis(4‑hydroxy‑2H‑chromen-2‑one)
21549-90-6

3,3'‑(2‑hydroxyphenylmethylene)bis(4‑hydroxy‑2H‑chromen-2‑one)

Conditions
ConditionsYield
With cholin hydroxide In water at 50℃; for 1h;99%
With phosphotungstic acid In water at 80℃; for 0.333333h; domino Knoevenagel type condensation/Michael reaction;98%
With Sulfonic Acid Functionalized Nanoporous Silica (SBA-Pr-SO3H) In ethanol; water for 0.5h;98%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

(E/Z)-3,7-dimethyl-2,6-octadienal
5392-40-5

(E/Z)-3,7-dimethyl-2,6-octadienal

2-methyl-2-(4-methylpent-3-enyl)-2H,5H-pyrano<3,2-c><1>benzopyran-5-one
132356-42-4

2-methyl-2-(4-methylpent-3-enyl)-2H,5H-pyrano<3,2-c><1>benzopyran-5-one

Conditions
ConditionsYield
With 2,4,8,10-Tetra-tert-butyl-6-hydroxydibenzo[d,f][1,3,2]dioxaphosphepine 6-oxide; sodium sulfate In toluene at 60℃; Inert atmosphere;99%
With 2,4,8,10-Tetra-tert-butyl-6-hydroxydibenzo[d,f][1,3,2]dioxaphosphepine 6-oxide; sodium sulfate In toluene at 60℃; Inert atmosphere; regioselective reaction;99%
With ethylenediamine diacetic acid In methanol for 3h; Ambient temperature;70%
With water at 80℃; for 6h; Domino Knoevenagel/6ϖ-electrocyclization;64%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

acetic anhydride
108-24-7

acetic anhydride

4-acetoxycoumarin
15059-36-6

4-acetoxycoumarin

Conditions
ConditionsYield
With 4-(dimethylamino)pyridine hydrochloride In toluene at 60℃; for 4h;99%
Stage #1: 4-hydroxy[1]benzopyran-2-one With manganese(II) iodide; naphthalene; lithium In tetrahydrofuran at 20℃; for 0.166667h; Inert atmosphere;
Stage #2: acetic anhydride In tetrahydrofuran at 20℃; for 1h; Inert atmosphere;
85%
With potassium tropolonato In acetonitrile at 70℃; for 4h;72%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

4-nitrobenzaldehdye
555-16-8

4-nitrobenzaldehdye

4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)-(4-nitro-phenyl)-methyl]-chromen-2-one
10172-70-0

4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)-(4-nitro-phenyl)-methyl]-chromen-2-one

Conditions
ConditionsYield
With N,N,N',N'-tetramethylguanidinium acetate at 25℃; for 2h;99%
With copper chromite nanoparticles In water at 20℃; for 0.0166667h; Green chemistry;99%
With 1,4-diazabicyclo[2.2.2]octane hydroacetate In water at 80℃; for 0.0833333h; Green chemistry;99%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

4-dimethylamino-benzaldehyde
100-10-7

4-dimethylamino-benzaldehyde

3,3′‐[(4‐dimethylaminophenyl)methylene]bis(4‐hydroxy‐2H‐chromen‐2‐one)
10172-76-6

3,3′‐[(4‐dimethylaminophenyl)methylene]bis(4‐hydroxy‐2H‐chromen‐2‐one)

Conditions
ConditionsYield
With 2H4N2*2H(1+)*F6Si(2-) In ethanol for 0.0333333h; Reflux; Green chemistry;99%
With glycerol-based carbon sulfonic acid In ethanol; water at 80℃; for 0.25h;96%
With lemon juice In water at 27 - 30℃; for 2.5h;96%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

4-chlorobenzaldehyde
104-88-1

4-chlorobenzaldehyde

malononitrile
109-77-3

malononitrile

2-amino-4-(4-chlorophenyl)-4,5-dihydro-5-oxopyrano[3,2-c]chromene-3-carbonitrile
177028-89-6

2-amino-4-(4-chlorophenyl)-4,5-dihydro-5-oxopyrano[3,2-c]chromene-3-carbonitrile

Conditions
ConditionsYield
With Lipase from Thermomyces lanuginosus immobilized on particle silica gel In water; dimethyl sulfoxide at 45℃; for 16h; Catalytic behavior; Reagent/catalyst; Solvent; Temperature;99%
With urea functionalized silica coated magneticcor shell Fe3-xTixO4 nanoparticle In ethanol; water for 0.25h; Reagent/catalyst; Reflux;98%
With perchloric acid modified cellulose In neat (no solvent) at 70℃; for 0.1h; Green chemistry;98%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

β-naphthaldehyde
66-99-9

β-naphthaldehyde

4-hydroxy-3-((4-hydroxy-2-oxo-2H-chromen-3-yl)(naphthalen-2-yl)methyl)-2H-chromen-2-one

4-hydroxy-3-((4-hydroxy-2-oxo-2H-chromen-3-yl)(naphthalen-2-yl)methyl)-2H-chromen-2-one

Conditions
ConditionsYield
With 1,4-diazabicyclo[2.2.2]octane hydroacetate In water at 80℃; for 0.1h; Green chemistry;99%
In ethanol for 24h; Heating;97%
With sulfonic acid-functionalized mesoporous silica nanoparticles In water at 80℃; for 0.25h; Green chemistry;95%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

terephthalaldehyde,
623-27-8

terephthalaldehyde,

NSC 158393
107421-16-9

NSC 158393

Conditions
ConditionsYield
With 1,4-diazabicyclo[2.2.2]octane hydroacetate In water at 80℃; for 0.0833333h; Green chemistry;99%
With sulfuric acid-modified polyethyleneglycol-6000 In neat (no solvent) at 70℃; for 0.0666667h; Knoevenagel Condensation; Green chemistry;98%
In water at 150℃; for 0.166667h; Microwave irradiation;86%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

4-fluorobenzaldehyde
459-57-4

4-fluorobenzaldehyde

SKI-213271

SKI-213271

Conditions
ConditionsYield
With cholin hydroxide In water at 50℃; for 1h;99%
With phosphotungstic acid In water at 80℃; for 0.25h; domino Knoevenagel type condensation/Michael reaction;98%
With sulfonic acid-functionalized mesoporous silica nanoparticles In water at 80℃; for 0.166667h; Green chemistry;98%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

4-bromo-benzaldehyde
1122-91-4

4-bromo-benzaldehyde

3,3'‑(4‑bromophenylmethylene)‑bis(4‑hydroxy‑2H‑chromen‑2‑one)

3,3'‑(4‑bromophenylmethylene)‑bis(4‑hydroxy‑2H‑chromen‑2‑one)

Conditions
ConditionsYield
With 1,4-diazabicyclo[2.2.2]octane hydroacetate In water at 80℃; for 0.0333333h; Green chemistry;99%
With Triton X-100 In water at 20℃; for 6h; Knoevenagel Condensation; Green chemistry;98%
In toluene at 90℃; for 0.25h; Reagent/catalyst;98%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

butyraldehyde
123-72-8

butyraldehyde

3,3'-(butane-1,1-diyl)bis(4-hydroxy-2H-chromen-2-one).
1821-18-7

3,3'-(butane-1,1-diyl)bis(4-hydroxy-2H-chromen-2-one).

Conditions
ConditionsYield
With 1,4-diazabicyclo[2.2.2]octane hydroacetate In water at 80℃; for 0.1h; Green chemistry;99%
With poly(2-acrylamido-2-methylpropanesulphonic acid-co-acrylamide) supported on magnetite nanoparticles In toluene at 90℃; for 0.55h;94%
In toluene at 90℃; for 0.5h; Reagent/catalyst;94%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

3-methylbenzene-1,2-diol
488-17-5

3-methylbenzene-1,2-diol

3,4-dihydroxy-2-methyl-6H-benzofuro[3,2-c][1]benzopyron-6-one

3,4-dihydroxy-2-methyl-6H-benzofuro[3,2-c][1]benzopyron-6-one

Conditions
ConditionsYield
With Trametes versicolor laccase; oxygen In acetate buffer at 20℃; for 3h; pH=4.37;99%
With laccase from Trametes versicolor at 20℃; for 3h; pH=4.4; aq. acetate buffer; Enzymatic reaction; regioselective reaction;99%
With sodium acetate; potassium hexacyanoferrate(III) In water for 1h; Michael addition reaction;95%
With laccase In aq. phosphate buffer at 20℃; for 24h; pH=7.15; Enzymatic reaction;76%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

5-Nitrosalicylaldehyde
97-51-8

5-Nitrosalicylaldehyde

7-(4-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-9-nitro-6H,7H-[1]benzopyrano[4,3-b][1]benzopyran-6-one

7-(4-hydroxy-2-oxo-2H-1-benzopyran-3-yl)-9-nitro-6H,7H-[1]benzopyrano[4,3-b][1]benzopyran-6-one

Conditions
ConditionsYield
at 80℃; for 2h;99%
With silica supported zirconium hydrogen sulfate In neat (no solvent) at 60℃; for 0.75h;99%
With TiO2-carbon nanotubes nanocomposite In water at 20℃; for 2h; Green chemistry;98%
isoquinoline
119-65-3

isoquinoline

4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

Cyclohexyl isocyanide
931-53-3

Cyclohexyl isocyanide

C25H24N2O3
1013099-16-5

C25H24N2O3

Conditions
ConditionsYield
In water at 70℃; for 12h;99%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

C17H18O3
1198426-96-8

C17H18O3

Conditions
ConditionsYield
With 2,4,8,10-Tetra-tert-butyl-6-hydroxydibenzo[d,f][1,3,2]dioxaphosphepine 6-oxide; sodium sulfate In toluene at 60℃; Inert atmosphere; regioselective reaction;99%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

(E)-1,1,1-trifluoro-4-phenyl-3-buten-2-one
3108-32-5, 86571-25-7

(E)-1,1,1-trifluoro-4-phenyl-3-buten-2-one

(4R)-2-hydroxy-4-phenyl-2-(trifluoromethyl)-3,4-dihydropyrano[3,2-c]chromen-5-(2H)one
1244390-29-1

(4R)-2-hydroxy-4-phenyl-2-(trifluoromethyl)-3,4-dihydropyrano[3,2-c]chromen-5-(2H)one

Conditions
ConditionsYield
With C29H29F6N3OS In toluene for 5h; Michael addition; optical yield given as %ee; enantioselective reaction;99%
4-hydroxy[1]benzopyran-2-one
1076-38-6

4-hydroxy[1]benzopyran-2-one

methyl benzylidenepyruvate
107969-78-8

methyl benzylidenepyruvate

(4R)-methyl 2-hydroxy-5-oxo-4-phenyl-2,3,4,5-tetrahydropyrano[3,2-c]chromene-2-carboxylate

(4R)-methyl 2-hydroxy-5-oxo-4-phenyl-2,3,4,5-tetrahydropyrano[3,2-c]chromene-2-carboxylate

Conditions
ConditionsYield
With C29H29F6N3OS In diethyl ether at 20℃; for 2h; Michael addition; optical yield given as %ee; enantioselective reaction;99%
With C37H31F6N3S at 20℃; for 12h; Solvent; Michael Addition; enantioselective reaction;92%

1076-38-6Relevant articles and documents

CONTROLLING EFFECT OF SUBSTITUENTS ON THE REDUCTION OF 4-SUBSTITUTED 3-NITROCOUMARINS BY SODIUM HYDROSULFITE

Parfenov, E. A.,Savel'ev, V. L.,Smirnov, L. D.

, p. 356 (1989)

-

Coumarin derivatives as potential inhibitors of acetylcholinesterase: Synthesis, molecular docking and biological studies

Singla, Shaffali,Piplani, Poonam

, p. 4587 - 4599 (2016)

A series of novel hybrids has been synthesized by linking coumarin moiety through an appropriate spacer to various substituted heterocyclic amines and evaluated as dual binding site acetylcholinesterase inhibitors for the treatment of cognitive dysfunction caused by increased hydrolysis of acetylcholine and scopolamine induced oxidative stress. Anti-amnesic activity of the compounds was evaluated using Morris water maze model at a dose of 1?mg/kg with reference to the standard, donepezil. Biochemical estimation of oxidative stress markers (lipid peroxidation, superoxide dismutase, and plasma nitrite) was carried out to assess the antioxidant potential of the synthesized molecules. Among all the synthesized compounds (15a–i, 16a–d, 17a–b), compound 15a [4-[3-(4-phenylpiperazin-1-yl)propoxy]-2H-chromen-2-one] displayed significant antiamnesic activity, AChE inhibitory activity (IC50?=?2.42?μM) and antioxidant activity in comparison to donepezil (IC50?=?1.82?μM). Molecular docking study of 15a indicated that it interacts with all the crucial amino acids present at the CAS, mid-gorge and PAS of TcAChE resulting in increased inhibition of AChE enzyme.

-

Shah et al.

, p. 677,678 (1960)

-

Synthesis of substituted 4-(4-((3-Nitro-2-oxo-2H-chromene-4-yl)amino)phenyl)morpholine-3-one coumarin derivatives

Sanghani, Yogesh J.,Koradiya, Suresh B.,Patel, Anilkumar S.

, p. 1461 - 1464 (2019)

A series of novel 4-(4-amino phenyl) morpholine-3-one substituted coumarin derivatives have been prepared by chloramine coupling reaction and were identified. The novel synthetic route involves nucleophilic substitution reaction of 4-chloro-3-nitro-2H-chromene-2- one with 4-(4-amino phenyl)morpholine-3-one. Due to the presence of nitro group in coumarin derivatives make substitution reaction easy and convenient at low temperature. Using DMF as solvent and K2CO3 as base various substituted 4-(4-((3-nitro-2-oxo-2H-chromen- 4-yl)amino)phenyl)morpholine-3-one derivatives (YS-1 to YS-10) can be obtain in good yield and high purity. Structural characterization of all synthesized compound was done by NMR, Mass and IR spectra.

Synthesis and biological evaluation of 4 arylcoumarin analogues as tubulin-targeting antitumor agents

Mutai, Peggoty,Breuzard, Gilles,Pagano, Alessandra,Allegro, Diane,Peyrot, Vincent,Chibale, Kelly

, p. 1652 - 1665 (2017)

The synthesis of twenty-six 4-arylcoumarin analogues of combretastatin A-4 (CA-4) led to the identification of two new compounds (25 and 26) with strong cytotoxic activity. Both compounds had a high cytotoxic effect on a CA-4-resistant colon adenocarcinoma cell line (HT29D4). The compounds affected cell cycle progression characterized by a mitotic block. The activity of these compounds against microtubules both in vitro and in cells was examined and both compounds were found to potently inhibit in vitro microtubule formation via a sub-stoichiometric mode like CA-4. By immunofluorescence, it was observed that both compounds induced strong microtubule network disruption. Our results provide a strong experimental basis to develop new potent anti-tubulin molecules targeting CA-4-resistant cancer cells.

Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity

Esposito, Francesca,Ambrosio, Francesca Alessandra,Maleddu, Rita,Costa, Giosuè,Rocca, Roberta,Maccioni, Elias,Catalano, Raffaella,Romeo, Isabella,Eleftheriou, Phaedra,Karia, Denish C.,Tsirides, Petros,Godvani, Nilesh,Pandya, Hetal,Corona, Angela,Alcaro, Stefano,Artese, Anna,Geronikaki, Athina,Tramontano, Enzo

, (2019)

A number of compounds targeting different processes of the Human Immunodeficiency Virus type 1 (HIV-1) life cycle have been developed in the continuing fight against AIDS. Coumarin-based molecules already proved to act as HIV-1 Protease (PR) or Integrase (IN) inhibitors and also to target HIV-1 reverse transcriptase (RT), blocking the DNA-dependent DNA-polymerase activity or the RNA-dependent DNA-polymerase activity working as common NNRTIs. In the present study, with the aim to exploit a coumarin-based scaffold to achieve the inhibition of multiple viral coded enzymatic functions, novel 4-hydroxy-2H, 5H-pyrano (3, 2-c) chromene–2, 5–dione derivatives were synthesized. The modeling studies calculated the theoretical binding affinity of the synthesized compounds on both HIV-1 IN and RT-associated Ribonuclease H (RNase H) active sites, which was confirmed by biological assays. Our results provide a basis for the identification of dual HIV-1 IN and RT RNase H inhibitors compounds.

One-pot two-step synthesis of 3-iodo-4-aryloxy coumarins and their Pd/C-catalyzed annulation to coumestans

Panda, Niranjan,Mattan, Irshad

, p. 7716 - 7725 (2018)

An efficient protocol for the synthesis of various coumestans from the intramolecular annulation of 3-iodo-4-aryloxy coumarins through C-H activation has been developed. When 3-iodo-4-aryloxy coumarins were treated with 10% Pd/C (0.3 mol% Pd) in the presence of sodium acetate, the corresponding coumestans were produced in good to excellent yield. Reusability of the palladium catalyst was investigated in up to three consecutive cycles and it was found that the yield of the reaction was almost unaltered. Sequential iodination and O-arylation of 4-hydroxy coumarins leading to the 3-iodo-4-aryloxy coumarins were also achieved in a one-pot two-step process starting from aryl iodides in high yield. Pivalic acid was revealed to be the most effective additive for the later method to produce 3-iodo-4-phenoxy coumarins. Different functional groups bearing electron-donating as well as withdrawing groups are also tolerant to the reaction conditions.

-

Merchant et al.

, p. 2061 (1972)

-

Combined Claisen Rearrangement and Oxidative Cyclization as a Route to Hydroxymethyl Dihydrofuran-Annulated Coumarins

Jayaprakash, Rao Y.,Chakravarthula, Venu

, p. 1014 - 1018 (2015)

A convenient and simple method for the synthesis of novel 3,4-dihydrofuran-annulated coumarins, 3-(hydroxymethyl)-2H-furo[3,2-c]chromen-4(3H)-ones 5a, 5b, 5c, 5d, 5e, 5f, 5g, by combined Claisen rearrangement and intramolecular regioselective oxidative cyclization of 4-O-allyl coumarin intermediates 3a, 3b, 3c, 3d, 3e, 3f, 3g using inexpensive oxidizing agent m-CPBA is described. The reaction proceeds smoothly by tandem epoxidation/regioselective 5-exo-tet-intramolecular ring opening. The structures of synthesized compounds are established on the basis of spectral data including IR, 1H NMR, and mass and elemental analyses.

Combining silver catalysis and organocatalysis: A sequential michael addition/hydroalkoxylation one-pot approach to annulated coumarins

Hack, Daniel,Chauhan, Pankaj,Deckers, Kristina,Hermann, Gary N.,Mertens, Lucas,Raabe, Gerhard,Enders, Dieter

, p. 5188 - 5191 (2014)

A highly stereoselective one-pot procedure for the synthesis of five-membered annulated hydroxycoumarins has been developed. By merging primary amine catalysis with silver catalysis, a series of functionalized coumarin derivatives were obtained in good yields (up to 91%) and good to excellent enantioselectivities (up to 99% ee) via a Michael addition/hydroalkoxylation reaction. Depending on the substituents on the enynone, the synthesis of annulated six-membered rings is also feasible.

Facile Synthesis of 4-Hydroxycoumarins by Sulfur-Assisted Carbonylation of 2'-Hydroxyacetophenones with Carbon Monoxide

Mizuno, Takumi,Nishiguchi, Ikuzo,Hirashima, Tsuneaki,Ogawa, Akiya,Kambe, Nobuaki,Sonoda, Noboru

, p. 257 - 259 (1988)

4-Hydroxycoumarins (4-hydroxy-2-oxo-2H-1-benzopyrans) were synthesized in good to excellent yields by C-carbonylation of 2'-hydroxyacetophenones with carbon monoxide in the presence of sulfur and bases.This is the first example of sulfur-assisted C-carbonylation with carbon monoxide.

Synthesis and reactivity of boron difluoride complexes of N,N-dimethylsalicylacetamide

Morris,Fang,Wishka,Han

, p. 3817 - 3820 (1993)

The synthesis and reactivity of a series of BF2 complexes of N,N-dimethylsalicylacetamide was examined.

Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: Design, synthesis, inhibitory activity and 3D-QSAR analysis

Wang, Zhong-Chang,Qin, Ya-Juan,Wang, Peng-Fei,Yang, Yong-An,Wen, Qing,Zhang, Xin,Qiu, Han-Yue,Duan, Yong-Tao,Wang, Yan-Ting,Sang, Ya-Li,Zhu, Hai-Liang

, p. 1 - 11 (2013)

A series of sulfonamides containing coumarin moieties had been prepared that showed a very interesting profile for the inhibition of two human carbonic anhydrase inhibitors. These compounds were evaluated for their ability to inhibit the enzymatic activity of the physiologically dominant isozymes hCA II and the tumor-associated isozyme hCA IX. The most potent inhibitor against hCA II and IX were compounds 5d (IC50 = 23 nM) and 5l (IC50 = 24 nM), respectively. These sulfonamides containing coumarin moieties may prove interesting lead candidates to target tumor-associated CA isozymes, wherein the CA domain is located extracellularly. Eighteen compounds were scrutinized by CoMFA and CoMSIA techniques of 3D quantitative structure-activity relationship. Nine of the compounds were evaluated for cytotoxicity against human macrophage.

Novel conjugates of podophyllotoxin and coumarin: Synthesis, cytotoxicities, cell cycle arrest, binding CT DNA and inhibition of Topo IIβ

Hao, Shu-Yi,Feng, Shi-Liang,Wang, Xing-Rong,Wang, Zhichao,Chen, Shi-Wu,Hui, Ling

, p. 2129 - 2135 (2019)

A series of conjugates of podophyllotoxin and coumarin were prepared using the click reaction, and their cytotoxicities against A549, HepG2, HeLa, and LoVo cells were evaluated. Among them, compound 14e exhibited the strongest cytotoxicities against these cancer cells with IC50 values of 4.9–17.5 μM. Furthermore, 14e disrupted microtubules and induced cell cycle arrest at G1 phase by regulating P21 and Cyclin D1 in LoVo cells. In addition, 14e bond CT DNA and selectively inhibited Topo IIβ over Topo IIα. Molecular docking model showed that 14e appeared to form stable hydrogen bonds with several DNA bases and residue Gln778. Taken together, these conjugates have the potential to be developed as anti-tumor drugs.

Energy transfer in coumarin-sensitised lanthanide luminescence: Investigation of the nature of the sensitiser and its distance to the lanthanide ion

Andres, Julien,Chauvin, Anne-Sophie

, p. 15981 - 15994 (2013)

A series of lanthanide complexes [Ln(dpxCy)3]3- have been synthesised. The ligands are composed of a coordinating dipicolinic acid backbone decorated with a polyoxyethylene arm fitted with a coumarin moiety at its extremity. The nature of the coumarin as well as the length of the linker have been varied. Upon excitation at 320 nm, the coumarin exclusively acts as an antenna while the dipicolinic acid core is not excited. Upon excitation below 300 nm, both parts are excited. With europium as a metal centre, the relaxation of the europium ion (intrinsic quantum yield ΦEuEu and radiative lifetime τr) is constant for all the studied ligands. Therefore, the observed differences in overall quantum yield (ΦEuL) in such systems come exclusively from the variation of the terminal coumarin. The overall quantum yields of the studied complexes are low (ΦEuL sens), the distance between the coumarin sensitiser and the lanthanide centre was explored in solution and compared to the solid state. In the solid state, a dramatic effect was confirmed, with an improvement of 80% in the quantum yield ΦEuL for short linkers ((-CH2CH2O-)n with n = 1 compared to n = 3). By monitoring the lifetime decay of the excited state of the lanthanide cation with nanosecond vs. microsecond time-resolved spectroscopy at low temperature, the sensitisation of the lanthanide ions by coumarin derivatives was demonstrated to mainly occur through the singlet excited state of the coumarin and not via the usual triplet pathway. No evidence of a different behaviour at room temperature was found by transient triplet-triplet absorption spectroscopy.

Copper(II)-Catalyzed Tandem Reaction: Synthesis of Furo[3,2- c]coumarin Derivatives and Evaluation for Photophysical Properties

Feng, Xi,Qin, Zhen,Cheng, Xinying,Liu, Dongyu,Peng, Yinghe,Huang, Huidan,Song, Bin,Bian, Jinlei,Li, Zhiyu

supporting information, p. 12537 - 12548 (2021/09/20)

An efficient protocol for synthesizing furo[3,2-c]coumarin derivatives is described. The novel reaction could afford the desired furocoumarins with good to excellent yields in a mild and rapid manner. Large substrate scope screening and scale-up preparation have also been accomplished, and selected compounds were evaluated for their photophysical properties.

Nickel-catalyzed deallylation of aryl allyl ethers with hydrosilanes

Ding, Guangni,Fan, Sijie,Wang, Jingyang,Wang, Yu,Wu, Xiaoyu,Xie, Xiaomin,Yang, Liqun,Zhang, Zhaoguo

, (2021/09/28)

An efficient and mild catalytic deallylation method of aryl allyl ethers is developed, with commercially available Ni(COD)2 as catalyst precursor, simple substituted bipyridine as ligand and air-stable hydrosilanes. The process is compatible with a variety of functional groups and the desired phenol products can be obtained with excellent yields and selectivity. Besides, by detection or isolation of key intermediates, mechanism studies confirm that the deallylation undergoes η3-allylnickel intermediate pathway.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1076-38-6